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Summary 
Lecithin,a major surface active substance of surfactant system of lung was estimated in 
bronchoalveolar lavage (SAL) tluid in four groups of healthy adult male albino rats. Rats 
from group I were not administered any drug and acted as controL Group II were 
administered histamine diphosphate.Group III were given H1 blocker (Pyrilamine 
maleate) followed by histamine diphosphate. Group IV received H:! blocker (Ranitidine 
hydrochloride) followed by histamine diphosphate. Lecithin content of BAL tluid in 
control group was compared with that in the other three groups. A significant decrease in 
lecithin content was observed in the rats that received either histamine diphosphate or H
1 
blocker followed by histamine diphosphate. However, compared to control rats no 
significant difference in lecithin content was seen in the rats that received H2 blocker 
followed by histamine :diphosphate. The results clearly indicate that the decrease in 
surface active lecithin content in BAL fluid following adrninistration of histamine 
diphosphate was unaffected by prior administration of H 1 blocker. but was blocked by 
prior administration of H::! blocker. It was concluded that histamine induced decrease in 
lecithin content of BAL fluid is mediated through H~ receptors. Since the predominant 
source of intraalveolar lecithin is secretion of Type II cells of alveolar epithelium, it is 
possible that Type li cells have H:! receptors, stimulation of which resulted in decreased 
intraalveolar lecithin. 
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Summary 
Lecithin,a major sutface active substance of surfactant system of lung was estimated in 
bronchoalveolar lavage (BAL) fluid in four groups of healthy adult male albino rats. Rats 
from group I were not administered any drug and acted as control. Group IT were 
administered histamine diphosphate.Group III were given Ht blocker (Pyrilamine 
maleate) followed by histatnine diphosphate. Group IV received H2 blocker (Ranitidine 
hydrochloride) fo11owed by histamine diphosphate. Lecithin content of BAL fluid in 
control group was compared with that in the other three groups. A significant decrease in 
lecithin content was observed in the rats that received either histamine diphosphate or H 1 
blocker followed by histatnine diphosphate. However, compared to control rats no 
significant difference in lecithin content was seen in the rats that received H2 blocker 
followed by histamine diphosphate. The results clearly indicate that the decrease in 
surface active lecithin content in BAL fluid following administration of histamine 
diphosphate was unaffected by prior administration of Ht blocker, but wa·s blocked by 
prior administration of H2 blocker. It was concluded that histamine induced decrease in 
lecithin content of BAL fluid is tnediated through H2 receptors. Since the predominant 
source of intraalveolar lecithin is secretion of Type II cells of alveolar epithelium, it is 
possible that Type II cells have H2 receptors, stimulation of which resulted in decreased 
intraalveolar lecithin. 
Introduction 
The surface tension forces of alveolar lining were demonstrated as early as 1929 by Von 
Neergard.However,a problem oriented approach to this phenomenon started with the 
discovery of increased surface tension forces leading to co11apse of lung and respiratory 
distress in hyaline membrane disease by Avery and Mead in 1959 (I). The presence of 
surfactant in normal lungs to act against the smface tension forces was demonstrated by 
Clements and Pattie {2,3). Later, it's biochemical composition in various species 
including human beings was explored {4,5,6). 
Pulmonary surfactant is a mixture of lipids, proteins and carbohydrates. About 90 o/o of 
pulmonary surfactant is lipids. A major portion of lipids is in the form of dipalmitoyl 
phosphotidyl choline, the other phospholipids like phosphotidyl glycine, phosphotidyl 
glycerol and phosphotidyl ethanolamine being in minor concentrations. The 
phospholipids form a surface active film lining the alveoli where as proteins help in 
stabilizing the film. 
Pulmonary surfactant is produced by Type II cells of alveolar epithelium. Lamellar bodies 
containing whorls of phospholipids are formed in these cells which are secreted as tubes 
of lipid, the tubular myelin in to the alveoli. The tubular myelin in turn forms the 
phospholipid film. As the lamellar bodies are formed in Type IT cells, the surfactant 
associated proteins are also incorporated in these structures. Further, there is a continuous 
secretion of surfactant into alveoli and uptake of surfactant from alveoli by Type IT cells 
maintaing homeostasis of this surface active material in the alveoli. 
The surface active property of pulmonary surfactant also acts against the tendency 
towards pulmonary edema (7). In the absence of surfactant, the combination of surface 
tension forces of alveoli and hydrostatic forces of pulmonary capillary can exceed the 
oncotic pressure in pulmonary capillary resulting in pulmonary edema. Pulmonary 
surfactant was also shown to assist macrophages in their scavanger function(&). It was 
also shown to have immuno suppressive property (9). 
The innervation to Type II cells being sparse, the regulation of surfactant was found to be 
mainly honnonal. Detailed reports on the effect of various hormones and other circulating 
chemicals on pulmonary surfactant system have been published .Since the importance of 
pulmonary surfactant in maintaining pulmonary patency was first observed in respiratory 
distress syndr01ne in newborn, the research was focussed on the development of 
pulmonary surfactant systetn during fetal life. Thyroxine and cortisol were shown to be 
essential in the develpoment of fetal pulmonary surfactant system (I 0). Ante partum 
glucocorticoid administration to tnothers to prevent respiratory distress syndrome in 
babies was advocated prior to the advent of exogenous administration of surfactant 
preparations to newborn with hyaline membrane disease( I I, 12). 
The author and Co-workers studied the effect of bronchodilators, anti-diuretics, 
hydrocortisone and histmnine on pulmonary surfactant system in adults.Administration of 
terbutaline and aminophylline led to decreased surface tension of alveolar extracts in 
adult rats( 13 ).Frusemide also had similar effect(l4 ).Administration of either 
hydrocortisone or histamine resulted in decreased lecithin levels in bronchoalveolar 
lavage fluid in adult rats( 15, 16).The present study was designed to identify the type of 
histamine receptor through which the effect of histamine is probably mediated. 
Materials and methods 
Healthy adult male albino rats of wistar strain weighing between 200-220 gm were used 
for the study.The animals were maintained in cages with free access to air, food and 
water. 
Broncho-alveolar lavage (BAL) is a standard procedure to assay various components of 
pulmonary surfactant system( 17). Lecithin is the major surface active phospholipid of 
pulmonary surfactant system. Thus, assay of lecithin in BAL fluid was employed in the 
present study to identify the type of histamine receptor responsible for histamine induced 
decrease in lecithin levels in BAL fluid. 
Broncho alveolar lavage: 
The rats were given pentobarbitone sodiutn intraperitoneally at a dose of 40 mg/kg.The 
anaesthetised ani1nals were incised from xiphisternum to chin. The thorax was opened 
and lungs along with trachea were isolated. The trachea was cannulated and alveoli were 
rinsed with normal saline via the airway. Each time 10 ml of normal saline was 
introduced via the trachea,and, the fluid was retained in the lungs for one minute. Then, it 
was rinsed back and forth,and aspirated. The procedure was repeated till a volume of 
about 15 ml was extracted for each animal. 
Lungs which had abnormal appearence,as for example,haemorhagic spots or·patches were 
not subjected to lavage. Samples from lungs which showed leakage of fluid during 
lavage,and lavage fluid which was contaminated with blood or not clear was not used for 
estimation of lecithin. Further,smnples collected with less than 70% of retrieval of 
instilled saline were also not used for determination of lecithin content. 
Assay of lecithin: 
Assay of lecithin was performed by enzymatic method using chemicals and protocol 
supplied by Boehringer-Mannheiin. 
In brief, it consists of hydrolysis of lecithin to phosphorylcholine. Phosphorylcholine is 
then hydrolysed to choline. Phosphorylation of choline in presence of ATP yields 
phosphorylcholine and ADP. Reconversion of ADP to ATP yields pyruvate.Reduction of 
pyruvate to lactate by oxidation of NADH gives lactate and NAD. The oxidised NADH is 
equivalent to lecithin and is estimated by spectrophotometry. 
In brief, the steps are: 
I. Hydrolysis of lecithin 
Lechitin was hydrolyzed by the enzyme phospholipasec and alkaline phosphatase at 
ph 8.0. 
phospholopase c 
Lecithin + H20 --------------------> I, 2 diglyceride + phosphorylcholine 
phosphorylcholine is hydrolyzed by alkaline phosphatase to choline and inorganic 
phosphate. 
alkaline phosphatase 
Phosphorylcholine + H20--------------------> choline+ P04 3-
2. Determination of the hydrolyzed lecithin. 
After inactivation of the alkaline phosphatase by heating the solution in a boiling 
water bath, choline was phosphorylated in the presence of ATP to 
phosphorylcholine by enzyme choline kinase 
choline Kinase 
Choline+ A.T.P ------------------> phosphorylcholine + ADP . 
The ADP formed was reconverted by pyruvate kinase with phosphoenol pyruvate 
in to A TP with the formation of pyruvate. 
pyruvate kinase 
ADP +Phosphoenolpyruvate ------------------------>ATP +pyruvate 
In the presence of lactate dehydrogenase (LDH), pyruvate was reduced to lactate by 
reduced Nicotinamide- adenine dinucleotide (NADH) with oxidation of NADH to 
NAD. 
LDH 
Pyruvate+ NADH -------->Lactate+ NAD + 
The amount of NADH oxidised in the above reaction is stoichiometric with the 
amount of lecithin . NADH is determined by means of it's absorbance at 340 nm. 
Experimental protocol: 
The animals were divided into 4 groups of 8 each. 
Rats from group I were not administered any drug and lecithin content in BAL fluid in 
this group of animals acted as control. 
Rats from group II were adminstered 0.06 mg per animal of histamine diphosphate (sigma 
chemical company) subcutaneously. The dose of histamine administered did not produce 
any untoward effects in the pilot experiments. After I 0 minutes of administration of 
histamine, BAL was performed and lecithin content was estimated. 
Group III were given 0.25 n1g per animal of pyrilamine maleate (sigma chemical 
company), a H 1 blocker. intraperitoneally. After 45 minutes, each of the animals was 
administered 0.06 mg of histamine diphosphate subcutaneously. Following I 0 minutes of 
administration of histamine, lecithin content in BAL fluid was estimated. 
Group IV were injected 0.25 mg per animal of ranitidine hydrochloride (sigma chemical 
company), a H2 blocker, intraperitoneally. Following 45 minutes of administration of 
ranitidine, each of the animals was given 0.06 mg of histamine diphosphate 
subcutaneously. After 10 tninutes of injection of histamine, BAL was performed and 
lecithin content was estimated. 
The doses of histamine blockers administered were equivalent to therapeutic doses 
employed in adult human beings. 
Statistical analysis: 
Statistical analysis of the results obtained was done using Student's unpaired t-test. 
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Discussion 
A significant reduction in lecithin content in bronchoalveolar lavage (BAL) fluid was 
observed within I 0 minutes of administration of histamine. Since lecithin is the 
predominant surface active substance in the pulmonary surfactant system , the finding 
indicates an acute effect of decrease in pulmonary surfactant activity with administration 
of histamine. 
Mechanism of decreased lecithin levels following adtninistration of histamine can not be 
ascertained from the present study. Type II alveolar cells constantly secrete pulmonary 
surfactant into the alveoli. Reuptake of this substance from the alveoli by the same cells 
maintains homeostasis of this surface active material in the alveoli( 18). Thus, the 
administered histamine might have inhibited the secretion or stimulated the uptake or 
both. Some of the smfactant associated proteins inhibit secretion and some facilitate 
uptake(l9,20). The effect observed in this study could also be due to secretion of these 
proteins. Further studies rnay help identification of the mechanism involved in the 
reduction of lecithin content. 
Lecithin constitutes 60-70% of the smface active materials found in the pulmonary 
surfactant system. These surface active materials reduce surface tension forces of alveolar 
lining and prevent collapsing tendency. Reduction in pulmonary surfactant activity leads 
to increased work of breathing and respiratory distress. A significant reduction in lecithin 
level was observed in the present study even at a dose that did not produce any untoward 
effects in the animals. Histamine is a comtnon mediator in many allergic disorders. It is 
possible that reduction in lecithin levels may be one of the factors responsible for the 
respiratory disability in allergic diseases like bronchial asthma and pulmonary 
aspergillosis. The present study is in experimental animals and it may not be possible to 
extrapolate data frmn experimental animals to human beings. Assay of lecithin in BAL 
fluid in the above patients may elucidate the effect of histamine on surfact~nt system of 
lung in adult human beings. 
Decrease in lecithin content in BAL fluid following administration of histamine was 
unaffected by prior administration of H, blocker (pyrilamine maleate) , but was blocked 
by prior administration of H2 blocker (ranitidine hydrochloride). This indicates that 
histamine induced decrease in lecithin content of BAL fluid observed in the present study 
was mediated through H2 receptors. Since the predominant source of intraalveolar 
lecithin is secretion of Type II cells of alveolar epithelium, it is possible that Type II cells 
have H2 receptors, stimulation of which resulted in decreased intraalveolar lecithin. 
Cheng M and Brown LA have reported stimulation of p~osphatidyl choline secretion by 
histamine in alveolar Type II cell cultures of adult rats whtch could be blocked by both H, 
antagonist (pyrilamine) and H2 antagonist (cimetidine)(21 ). Gilfillan AM, Lewis AJ and 
Rooney SA observed stimulation of phosphotidyl choline secretion in Type II cell 
cultures of adult rats by thiazinamimn chloride which has antihistaminic properties. They 
have also observed stimulation of phosphotidyl choline secretion by H 1 antagonists 
(promethazine and pyrilamine) but not by H2 antagonist (cimetidine). However, they were 
unable to demonstrate any inhibitory effect of histamine it self in the invitro culture of 
Type II pneumocytes(22). In the present study conducted on adult rats, a significant 
reduction in intraalveolar lecithin levels was observed which could be blocked by H2 
antagonist (ranitidine) but not by H1 antagonist (pyrilatnine). The findings in the present 
study emphasize the fact that invitro and invivo effects may be different in view of the 
complexity of responses in the whole animal. Further, though the findings in various 
studies are not similar, it appears certain that histamine has a role in the regulation of 
secretion of pulmonary surfactant. 
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